These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3185535)

  • 21. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
    Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
    J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanism of functioning of specific sites of interdomain D-E binding of fibrin molecules: interaction of fibrinogen with the N-terminal disulfide node of fibrin].
    Rybachuk VN; Pozdniakova TM
    Ukr Biokhim Zh (1978); 1986; 58(4):3-9. PubMed ID: 3739028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
    Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differences between the complexes formed by monomeric fibrin with fragment D and dimer D].
    Belitser VA; Platonova TN; Pozdniakova TM
    Ukr Biokhim Zh (1978); 1983; 55(3):243-9. PubMed ID: 6868146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M; Baba M; Morimoto K; Nakamikawa C
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
    Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
    Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
    Lu PD; Galanakis DK; Ghebrehiwet B; Peerschke EI
    Clin Immunol; 1999 Mar; 90(3):360-7. PubMed ID: 10075865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D.
    Knoll D; Hantgan R; Williams J; McDonagh J; Hermans J
    Biochemistry; 1984 Jul; 23(16):3708-15. PubMed ID: 6236846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of fibrin assembly by fragment D and its dimer derived from fibrinogen and stabilized fibrin. Evidence for the two-step type of inhibition].
    Platonova TN; Musialkovskaia AA; Tolstykh VM; Belitser VA
    Biokhimiia; 1980 Oct; 45(10):1780-7. PubMed ID: 7236767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the fragment D-fibrin monomer complex formation by salting-out fractionation].
    Pozdniakova TM; Rybachuk VN; Vovk Ev
    Biokhimiia; 1982 Jun; 47(6):971-6. PubMed ID: 7115809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
    Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
    Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M; Chen JP
    Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intrinsic fluorescence of human fibrinogen and its fragments D and E.
    Kowalska MA; Cierniewski CS
    Thromb Haemost; 1982 Aug; 48(1):21-3. PubMed ID: 7135341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
    Grinenko TV; Tret'iachenko VG; Kudinov SA; Medved' LV
    Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.